Spiegelman Daniel K's Form 4 filing
Myriad Genetics Inc (MYGN) · filed Jun 2, 2023
- Accession no.
- 0001238403-23-000002
- Filed
- Jun 2, 2023
- Trade date
- Jun 1-2, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $198.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spiegelman Daniel KCIK 0001238403 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | Common Stock | AGrant or awardAcquired | +15,151 | $0.00 | $0 | 49,131 | Direct | |
| Jun 2, 2023 | Common Stock | SSaleDisposed | −8,638 | $23.01 | −$198,760.38 | 40,493 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.